Economic Guidance Panel Changes to Minimize Post-Progression Treatment Effects by the Pan-Canadian Oncology Drug Review in Economic Evaluations Assessing Cancer Drugs
May 1, 2018, 00:00 AM
10.1016/j.jval.2018.04.020
https://www.valueinhealthjournal.com/article/S1098-3015(18)30320-6/fulltext
Section Title :
Section Order :
1160
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)30320-6&doi=10.1016/j.jval.2018.04.020